Lumibird SA
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications. It operates in two divisions, Photonics and Medical. The company offers solid-state lasers, laser diodes and components, fiber lasers and amplifiers, and high-power fiber lasers; and doppler wind LiDAR, time-of-flight LiDAR and rangefinders, military lasers rangefinders, and medical a… Read more
Lumibird SA - Asset Resilience Ratio
Lumibird SA (LBIRD) has an Asset Resilience Ratio of 22.85% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Lumibird SA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Lumibird SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €45.19 Million | 10.37% |
| Short-term Investments | €54.43 Million | 12.49% |
| Total Liquid Assets | €99.62 Million | 22.85% |
Asset Resilience Insights
- Good Liquidity Position: Lumibird SA maintains a healthy 22.85% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Lumibird SA Industry Peers by Asset Resilience Ratio
Compare Lumibird SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for Lumibird SA (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Lumibird SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 12.73% | €54.71 Million | €429.80 Million | +4.81pp |
| 2023-12-31 | 7.92% | €32.08 Million | €405.25 Million | +1.13pp |
| 2022-12-31 | 6.79% | €25.26 Million | €372.04 Million | +6.07pp |
| 2021-12-31 | 0.72% | €2.50 Million | €347.62 Million | +38.87pp |
| 2020-12-31 | -38.15% | €-116.51 Million | €305.43 Million | -38.16pp |
| 2019-12-31 | 0.02% | €30.00K | €193.76 Million | -0.02pp |
| 2018-12-31 | 0.04% | €53.00K | €151.03 Million | -14.26pp |
| 2017-12-31 | 14.30% | €17.31 Million | €121.08 Million | +10.51pp |
| 2016-12-31 | 3.79% | €2.32 Million | €61.19 Million | +13.41pp |
| 2015-12-31 | -9.63% | €-5.88 Million | €61.11 Million | -11.23pp |
| 2013-12-31 | 1.60% | €825.00K | €51.49 Million | +0.06pp |
| 2012-12-31 | 1.54% | €814.00K | €52.71 Million | +0.45pp |
| 2011-12-31 | 1.09% | €637.00K | €58.29 Million | +0.09pp |
| 2010-12-31 | 1.01% | €557.00K | €55.28 Million | +0.16pp |
| 2009-12-31 | 0.85% | €463.00K | €54.77 Million | +0.02pp |
| 2007-12-31 | 0.82% | €572.00K | €69.41 Million | +0.15pp |
| 2006-12-31 | 0.67% | €372.00K | €55.22 Million | -0.04pp |
| 2005-12-31 | 0.72% | €314.00K | €43.91 Million | +0.17pp |
| 2004-12-31 | 0.54% | €147.00K | €27.20 Million | -0.59pp |
| 2003-12-31 | 1.13% | €317.00K | €28.16 Million | +0.91pp |
| 2002-12-31 | 0.22% | €69.00K | €31.96 Million | +0.12pp |
| 2001-12-31 | 0.09% | €31.00K | €33.26 Million | -0.02pp |
| 2000-12-31 | 0.12% | €206.00K | €175.71 Million | -- |